← SynDRA
SYN0709612
SynDRA canonical compound SYN0709612 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | GRIN1 |
| Mechanism of action | glutamate receptor antagonist |
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- CGA
- ESR1
- GMNN
- HCRTR1
- HCRTR2
- HSD17B10
- IDH1
- LMNA
- MAPT
- NFE2L2
- PIN1
- POLI
- PTH1R
- SMAD3
- TDP1
- USP2
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Cross-references
Synonyms
- Sdz 220-581
- RefChem:405767
- DTXCID201577737
- C16H17ClNO5P
- SDZ220-581
- NCGC00025079-01
- Tocris-1250
- Biomol-NT_000193
- BPBio1_001218
- orb1708543
- SCHEMBL2394195
- SCHEMBL29369964
- GLXC-01819
- HMS3412C08
- HMS3676C08
- ZGA57517
- EX-A14589
- MFCD09878263
- AKOS024456490
- CS-1475
- NCGC00025079-02
- NCGC00025079-09
- HY-13059
- MS-32530
- F84954
- T12889
- SR-01000597426
- SR-01000597426-1
- BRD-K27168049-001-02-8
- 3-(2-Chlorophenyl)-5-(phosphonomethyl)-L-phenylalanine
Look up SYN0709612 in the interactive SynDRA portal →